# Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-hl-24-012-single-source-molecular-atlas-of-lung-development-program/  
Official notice: https://www.grants.gov/search-results-detail/349294

> National Institutes of Health offered grants of up to $300,000 to small businesses. Applications closed on September 6, 2023.

| Field | Value |
|---|---|
| Opportunity number | RFA-HL-24-012 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | September 6, 2023 |
| Award ceiling | $300,000 |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.838 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following:See full Notice of Funding Opportunity for additional information on eligibility.

## What the grant funds

The objective of the Molecular Atlas of Lung Development (LungMAP) program is to build a comprehensive molecular and cellular atlas of the human lung to serve as a reference platform to better understand both normal biology and disease pathobiology, and to identify critical cellular components, molecular pathways, and novel therapeutic targets in lung disease. LungMAP is an open access resource integrating multi-scale, high-content, high-resolution information to define lung cells with gene expression, physiological states, 3-dimensional locations, as well as developmental and pathological trajectories.

## Questions people ask

### Is RFA-HL-24-012 still open?

No. It closed on September 6, 2023.

### Who can apply for Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed)?

Closed September 6, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $300,000 each.

### Who has won Lung Diseases Research grants before?

The largest recipients over five fiscal years were The General Hospital Corporation, New England Research Institutes Inc, The Trustees of the University of Pennsylvania. The program made 5 awards worth $8.7 million in that time.